Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (Diluted Average) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $22.8 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1.59% to $22.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $22.8 million, a 1.59% increase, with the full-year FY2024 number at $22.8 million, up 1.59% from a year prior.
  • Shares Outstanding (Diluted Average) was $22.8 million for Q4 2024 at Lemaitre Vascular, up from $22.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $22.8 million in Q4 2024 to a low of $21.5 million in Q4 2021.
  • A 4-year average of $22.2 million and a median of $22.3 million in 2022 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 3.24% in 2022, then grew 1.14% in 2023.
  • Lemaitre Vascular's Shares Outstanding (Diluted Average) stood at $21.5 million in 2021, then grew by 3.24% to $22.2 million in 2022, then increased by 1.14% to $22.4 million in 2023, then rose by 1.59% to $22.8 million in 2024.
  • Per Business Quant, the three most recent readings for LMAT's Shares Outstanding (Diluted Average) are $22.8 million (Q4 2024), $22.4 million (Q4 2023), and $22.2 million (Q4 2022).